Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma

Gene Therapy against Murine Melanoma B16F10-Nex2 Using IL-13Rα2-Fc Chimera and Interleukin 12 in Association with a Cyclopalladated Drug

(2014) Flavia Hebeler-Barbosa et al.   Translational Oncology

Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential

(2009) Mizue Terai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma

(2009) W. K. Nevala et al.   CLINICAL CANCER RESEARCH

Impaired interferon signaling is a common immune defect in human cancer

(2009) R. J. Critchley-Thorne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY

Strategies for use of IL-10 or its antagonists in human disease

(2008) Anne O'Garra et al.   IMMUNOLOGICAL REVIEWS